Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our Best Content in Your Email

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Insiders  |  Valuation

ACASTI PHARMA INC V.ACST

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ACST

"Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders."
View modes: 
0 stars

Must see...Latest Trump Executive Order

https://youtu.be/41XLnG3YqFY  rate and reply
0 stars

Volume

has perked up today on Nasdaq.. So far in the day it is already at 270k and share price is up 12.84% so let's see what is the likely news since NEPT reports tomorrow  rate and reply
0 stars

RE:More dilution

I was going to Bid 1,000@ $1.41 but now with the proposed addition of 7 million shares and the dilution that will bring, it's a huge cash injection which will be helpful, does anyone know what...read more
1 star

More dilution

  Acasti Pharma Inc. ("Acasti", "Acasti Pharma" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST) today announced that it has received a receipt for a...read more
0 stars

Acasti Pharma Appoints Linda O'Keefe as CFO

LAVAL, QUEBEC--(Marketwired - Nov 28, 2016) - Acasti Pharma Inc. (ACST)(TSX VENTURE:ACST) today announced that Linda O'Keefe has been named chief financial officer. Ms. O'Keefe brings to...read more
0 stars

New Acasti patent

Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre   http://www.stockhouse.com/news/press-releases/2016/10/26/acasti-pharma-builds-intellectual-property...read more
0.5 stars

Email reply from Jessica Dyas Acasti Pharma Account Manager

Do not be Scammed by the Pump and Dump Ignore and hold your positions in Acasti. They are a good international company that deserved our support. Email Reply below: Date: Wed, Sep 14, 2016...read more
0 stars

Not surprising

As soon as something happens, n u t s show up and my ignore list goes up..   rate and reply
0 stars

Positive study results NO FDA APPROVAL

"We are confident that the results of this study support the 505(b)(2) regulatory pathway chosen by Acasti "TO GAIN" marketing approval of CaPre," said Jan D'Alvise, president...read more
0.5 stars

******This a a SCAM ********** BEWARE! !!!

I read them and fell for the scam too. ***** NOTICE THE POP-UP ADVERTISEMENTS ****** I have $33,000 sitting in my Direct Investing Account and I was almost FELL FOR this SCAM!!!!!! This has a 52-week...read more
0 stars

Time to Watch Acasti Pharma (V.APO)

Keep a close eye on Acasti Pharma (V.APO). Potential momentum continuation on study outcomes for its novel hypertriglyceridemia drug Check this out http://crweworld.com/article/press-releases...read more
0 stars

Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study

http://finance.yahoo.com/news/acasti-pharma-reports-positive-capre-120000754.html  rate and reply
0 stars

Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study

http://finance.yahoo.com/news/acasti-pharma-reports-positive-capre-120000754.html  rate and reply
3 stars

RE:the juwel...

- a money-pit - no results to show - takes more then halve a year to present "a path forward" they seem to have no urgency to get something done....what takes have a year????? well its...read more
0 stars

the juwel...

"Acasti has made important progress this quarter We expect to have a clear view of our path forward by the end of this year". 3 mil in losses/quarter They had revenue of $2000.- last...read more
0 stars

2 Q's: Why is the last post from last year..............and

Why no discussion of recent stock price and/or prospects ?  ( ! )   Popps  rate and reply
0 stars

Up 20% very active...

...any news?  rate and reply
0 stars

New CEO

 http://www.marketwired.com/press-release/jan-dalvise-appointed-president-ceo-of-acasti-pharma-tsx-venture-apo-2124294.htm  rate and reply
3 stars

The US government just said a drugmaker could market its...

Good news for Amarin is a better news for Acasti... http://finance.yahoo.com/news/us-government-just-said-drugmaker-195900964.html  rate and reply